Overall Survival (Os) Results From The Phase Iii Monaleesa-2 (Ml-2) Trial Of Postmenopausal Patients (Pts) With Hormone Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (Hr+/Her2l) Advanced Breast Cancer (Abc) Treated With Endocrine Therapy (Et) +/- Ribociclib (Rib)